Training activity information
Details
Review and select potential living donors for solid organ transplantation
Type
Developmental training activity (DTA)
Evidence requirements
Evidence the activity has been undertaken by the trainee.
Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.
An action plan to implement learning and/or to address skills or knowledge gaps identified.
Considerations
- Local and national procedures
- Factors affecting living donor selection
- National and international standards and legislation relating to living donor transplantation
- Local protocols for the clinical and laboratory work up of patients and living donors awaiting solid organ transplantation
- Clinical work up process, including medical evaluation, psychological evaluation and informed consent
- Patient centred care and support, including clinical urgency and benefits of living donation
Reflective practice guidance
The guidance below is provided to support reflection at different time points, providing you with questions to aid you to reflect for this training activity. They are provided for guidance and should not be considered as a mandatory checklist. Trainees should not be expected to provide answers to each of the guidance questions listed.
Before action
- Are you familiar with the local policies for living donor selection for solid organ transplantation?
- Have you reviewed the relevant learning outcomes for this module? Do you understand the importance of HLA matching and antibody compatibility in solid organ transplantation?
- What different types of data might you need to review (e.g., HLA typing results, antibody screening, medical history)?
- What deeper understanding of the complexities involved in selecting a suitable living donor might you gain? How might you learn to balance different factors, such as HLA compatibility, medical suitability, and logistical considerations?
- Could you develop your skills in critically evaluating patient and donor data?
- Have you discussed the process of living donor selection with your training officer, including the specific criteria and guidelines used in your laboratory?
- Have you reviewed any relevant standard operating procedures (SOPs) or national guidelines related to living donor selection for solid organ transplantation?
- Have you considered potential challenges, such as the presence of HLA antibodies, and how you might approach them?
- Have you reflected on your current knowledge of HLA and antibody testing and how this relates to transplant outcomes?
In action
- What specific data (e.g., HLA typing, antibody results, medical history) are you currently reviewing for potential living donors?
- What criteria are you using to assess the suitability of each potential donor based on local policies and guidelines?
- What decisions are you making about how potential donors should be reported at each stage of the review process?
- Are you finding any aspects of the data interpretation more straightforward than others? Which aspects require more careful consideration?
- Are you encountering any challenges in accessing or interpreting the required information?
- How confident are you in your ability to identify suitable potential living donors based on the data available?
- What new insights are you gaining about the factors that influence the selection of living donors for solid organ transplantation as you proceed?
- How is your understanding of HLA matching and antibody compatibility being applied in this practical scenario?
- If you encounter ambiguous data or conflicting information, what steps are you taking to clarify the situation?
- Are you considering alternative ways to approach the donor selection process if your initial strategy is not proving effective?
- Do you feel you need to seek guidance from a senior colleague on any specific aspects of the review?
On action
- What were the key pieces of information you had to consider when reviewing potential living donors (e.g., HLA typing results, antibody screening data, other relevant medical information)?
- What challenges or complexities arose during the review process?
- What decisions did you make regarding the suitability of potential donors, and what was the rationale behind those decisions?
- Did any particular patterns or trends emerge as you reviewed the data for multiple potential donors?
- How did the process compare to any expectations you had before undertaking the activity?
- What specific aspects of the HLA matching process for living donor transplantation became clearer to you?
- Did you gain a better understanding of the importance of specific data (e.g., particular HLA types, the presence or absence of certain antibodies)?
- Were there any unexpected challenges in interpreting the data or applying the selection criteria? What did you learn from these?
- In what ways did your reflect-in-action (your thoughts and decisions during the review) influence how you approached the selection process?
- What areas for continued development have you identified in your ability to review and select potential living donors?
- How will you apply the knowledge and insights gained from this activity to future tasks involving donor selection?
- What actions or ‘next steps’ will you take to further develop your understanding in this area (e.g., reviewing specific guidelines, discussing cases with senior colleagues)?
- Do you feel you need any additional support or resources to improve your skills in this area?
Beyond action
- Have you had the opportunity to compare your reflections and learning from this training activity with experiences from other training activities? For example, have you noticed any connections between the challenges faced in donor selection and the interpretation of crossmatch data or HLA antibody identification?
- Have you engaged in discussions with peers or colleagues about your experience of reviewing and selecting potential living donors? Has this shared experience altered your perspective or highlighted new considerations?
- Have you revisited your initial ‘reflect-on-action’ notes from this training activity in light of subsequent learning or experiences in the H&I lab? Have your initial conclusions evolved?
- How has your understanding of the key factors in living donor selection (e.g., HLA matching, antibody profiles) developed since undertaking this training activity? Can you identify specific instances where the learning from this activity has influenced how you approach similar tasks?
- Have the communication skills potentially used during this activity (even if through documentation) influenced how you now prepare reports or discuss potential donors with colleagues?
- Has your experience with this training activity contributed to your preparedness for observed ‘in-person’ assessments, such as Case-based Discussions that might touch upon donor selection principles?
- What transferable skills, such as critical evaluation of complex data and decision-making under pressure, did you develop or refine through this activity that will be valuable in future aspects of your role as a Clinical Scientist?
- What clear actions for continued development in the area of donor selection have emerged as you look back on this experience? Do you need to seek out further learning opportunities or specific case studies?
Relevant learning outcomes
| # | Outcome |
|---|---|
| # 4 |
Outcome
Interpret test results for the range of techniques performed. |
| # 6 |
Outcome
Practice in accordance with quality and accreditation standards. |